MedTrace Logo

Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF

NCT06367855 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-09-08

No results posted yet for this study

Summary

Researchers are considering Dexamethasone as preemptive medication before minimally invasive spine fusion surgery to minimize postoperative back pain with minimal side effects, aiming to enhance the effectiveness of surgery and improve patient outcomes.

Conditions

  • Spinal Stenosis Lumbar
  • Disc Degeneration
  • Disc Disease
  • Fusion of Spine
  • Surgery

Interventions

DRUG

Dexamethasone

long-acting corticosteroid IV route

DRUG

Normal saline

normal saline

Sponsors & Collaborators

  • Potsawat Surabotsopon

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-11-30
Completion
2025-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06367855 on ClinicalTrials.gov